Philanthropist and former Citigroup Chairman, Sandy Weill, announces a fresh $100 million donation to promote AI application in a West Coast cancer research center.
In a significant stride towards advancing cancer research and treatment, the Weill Cancer Hub West has been established as a $200 million collaborative endeavour between UC San Francisco and Stanford University, funded by the Weill Family Foundation. The initiative, which has been in the planning stages for two years, aims to revolutionise cancer research and care over the next decade.
The Weill Cancer Hub West's specific goals are threefold: to delve deeper into human cells and tissues to understand how cancer develops and varies among individual patients, to harness the power of data science to improve early detection, diagnosis, and the development of effective cancer treatments, and to develop new therapies aimed at overcoming drug resistance and poor treatment responses.
The initiative will kickstart four team-science projects at the forefront of cellular engineering, CRISPR gene-editing technologies, and artificial intelligence applications in cancer research. These projects are designed to leverage recent advances in biology, immunology, and data science through cross-disciplinary collaboration between UCSF and Stanford scientists.
One of the projects will utilise the gene editing tool CRISPR to engineer immune cells inside the body to fight cancer. Another project aims to build personalised cells that are weaponised to target solid tumours like breast cancer or pancreatic cancer. The Weill Cancer Hub West's AI project is anticipated to keep the research momentum going, as Mackall from Stanford notes, "This gift-with a capital G- is going to allow us to keep our foot on the gas and not let up because of other funding challenges."
The Weill Cancer Hub West's research efforts will also explore whether different diets, such as a ketogenic diet, can slow cancer progression. Additionally, the link between cancer, diet, and drugs, including the popular weight loss drugs called GLP-1 agonists (like Ozempic and Wegovy), will be investigated.
Notably, the group will also study the potential benefits of AI in guiding treatment, especially for third- or fourth-line treatments, in cases of colorectal cancer where there is no established standard. This AI-based project is expected to be particularly beneficial, particularly in guiding treatment for patients who have exhausted conventional treatment options.
The Weill Cancer Hub West's research team will include renowned scientists such as Jennifer Doudna, the UC Berkeley biochemist who shared the Nobel prize in chemistry for the CRISPR gene editing breakthrough.
Sandy Weill, the former CEO and chairman of banking giant Citigroup, and his wife Joan are the major donors to the Weill Cancer Hub West. Other billionaire donors, such as Mark Zuckerberg and Priscilla Chan, Sean Parker, Sergey Brin, and Patrick Collison, have also embraced collaborative research in various fields.
Minor, the dean of Stanford's medical school and vice president for medical affairs at Stanford, expects to see improvements in cancer diagnosis, treatment, and prevention in a matter of years. The Weill Cancer Hub West also plans to raise an additional $100 million through a matching grant, with a quarter of the matching funds already raised.
The Weill family has previously funded collaborative neuroscience research and has also pledged funding for the Weill Cancer Hub East, a collaborative undertaking between Cornell University's Weill Cornell Medicine, Princeton University, Rockefeller University, and the Ludwig Institute for Cancer Research. As Sandy Weill, now age 92, devotes most of his time to philanthropy via his charitable foundation, the Weill Cancer Hub West marks another significant contribution to scientific research and healthcare.
[1] [4] References omitted for brevity.
- Sandy and Joan Weill, through their philanthropy, have funded the establishment of the Weill Cancer Hub West, a collaborative initiative between UC San Francisco and Stanford University, aimed at understanding the development and variations of cancer in individual patients and developing new therapies to combat drug resistance.
- In the realm of health and wellness, the Weill Cancer Hub West will investigate the potential benefits of artificial intelligence in guiding treatments, particularly for colorectal cancer patients who have exhausted conventional options, as well as the link between cancer, diet, and drugs like GLP-1 agonists.
- The Weill Cancer Hub West, along with its team of renowned scientists such as Jennifer Doudna, creates a platform for interdisciplinary collaboration between UCSF and Stanford scientists, focusing on cutting-edge research in areas like cellular engineering, CRISPR gene-editing technologies, and data science, as they work towards improving cancer diagnosis, treatment, and prevention.
